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REFEREE REPORTS
Referee #1:
The manuscript by Gomez et al studies the localization of Sororin, a regulator of cohesin, in mouse spermatocytes. By using their technique of spermatocyte spreading, they find that Sororin localizes at the central regions (CRs) of the synaptonemal complex during meiosis. This localization pattern is different from that of cohesin complexes, which are known to localize at axial elements. Their analyses of spermatocytes from Rec8-/-mice and Smc1b-/-mice show that the localization of Sororin at CRs is independent of cohesin. Based on these data, they speculate that Sororin has a role at CRs independent of cohesin.
A novel point of this manuscript is cohesin-independent localization of Sororin. This conclusion is robustly supported by their careful analysis that compares the localization of Sororin and cohesins and by their analysis of cohesin-KO mice. Although the function of Sororin independent of cohesin is unclear from the data shown in the manuscript, the description of cohesin-independent localization of Sororin would be a significant contribution to the field and interest researchers in the specific area. The data are of high quality and the images are impressively beautiful. Sororin's potential roles independent of cohesin are appropriately discussed. I believe the current manuscript is suitable for publication in EMBO reports.
I have only one minor suggestion that would further improve the manuscript. -It would be helpful to further confirm their conclusion if they could include a data for double staining of Rec8-myc and Sororin at early zygotene in the manuscript.
Referee #2:
In this study, the authors have analyzed the localization of Sororin, a protein required for sister chromatid cohesion in somatic cells, by immunofluorescence during male mouse meiosis. In somatic cells, Sororin contributes to sister chromatid cohesion by preventing the release of cohesin complexes from DNA. Sororin is thought to achieve this by binding to cohesin and by inhibiting Wapl, a protein that can release cohesin from DNA. There are conflicting reports about how Sororin interacts with cohesin, both the cohesin subunits Pds5A and Pds5B (Nishiyama et al., Cell 2010) and SA2 have been reported as Sororin binding partners (Zhang and Pati, Cell Cycle 2015). Specific isoforms of cohesin complexes also exist in meiotic cells, where they are essential for proper homologous pairing, chromosome cohesion and chromosome segregation, but it is not known if Sororin is expressed in meiotic cells and has a function in sister chromatid cohesion in meiosis.
In this study, the authors describe staining patterns obtained with Sororin antibodies in surfacespread mouse spermatocytes and show that this pattern changes in interesting ways during meiotic progression. From zygotene to diplotene Sororin antibodies stain the central region of the synaptonemal complex (SC), where the two homologous chromosomes are synapsed and where the protein SYCP1 is located. Surprisingly, during these stages of prophase I, Sororin staining does not co-localize with cohesin, its binding partner in somatic cells. Cohesin is known to be present at axial/lateral elements, where also Wapl and Pds5B have previously been detected. Moreover, the authors provide evidence that Sororin localization to the central region of the SC does not depend on the meiotic-specific cohesin subunits Rec8 and Smc1b. Based on these results the authors suggest that Sororin might be involved in chromosome pairing and synapsis and that its functions during early stages of prophase I might be independent of cohesin complexes. From late diplotene to anaphase II, Sororin staining is detected at centromeres, where cohesin is known to exist, and its localization there depends on Sugoshin2 (Sgo2). Based on this observation the authors suggest that Sororin might work in combination with Sgo2 in order to protect centromeric cohesion until anaphase II onset. In summary, the authors propose that Sororin might have two distinct and independent roles during male mouse meiosis, a cohesin independent role in chromosome pairing and synapsis, and a cohesin dependent role in protecting centromeric cohesion.
This manuscript addresses an interesting topic, as previous work has revealed the importance of Sororin for sister chromatid cohesion in somatic cells, but nothing is known about the existence and possible functions of Sororin in meiotic cells. The presented microscopic data are of high quality, and the observed staining patterns very interesting. However, this study has several limitations. One is the lack of loss-of-function data. But one can argue that this is beyond the scope of this study, and since we know nothing about Sororin in meiosis and the observed staining patterns are interesting and suggestive, I would argue that it is fine to publish this study without functional data, as long as it is clear that the manuscript does not overstate any conclusions (see for example comment 1 on the title of the manuscript below). The second limitation is more serious. How do we know that the observed staining patterns are representing the location of Sororin? More controls will be needed to address this central point (see comment 2 below with some suggestions for what could be done). This is particularly important as in somatic cells Sororin is thought to be recruited to chromatin only via cohesin, so can the authors exclude that the central element staining observed with Sororin antibodies is not caused by a cross-reacting antigen? The third limitation is whether the authors can really exclude that the observed Sororin staining pattern is cohesin independent. It would be technically possible to address this more rigorously and I would recommend doing this (see points 3 and 4 below). If these points can be addressed I would support publication of this interesting study.
Specific points:
1. The authors do not provide functional data supporting the role of Sororin in chromosome pairing and centromere dynamics in male mouse meiosis. To properly test the role of Sororin in these processes would have been necessary to analyze chromosome pairing and centromere dynamics in the absence of Sororin. I would suggest that the authors change the title in a way that it reflects what the manuscript actually shows, for example by saying "Sororin localizes to the central elements during mouse male meiosis independently of meiotic cohesin complexes".
2. As already mentioned, more work is required to control the specificity of the Sororin antibodies used. For example: Do the two Sororin antibodies mentioned in the Methods give comparable staining patterns? This should be shown. How does the entire Western blot in Figure S1 look like, are there no other cross-reacting bands? Do these antibodies also cross-react with Sororin in somatic cells? This could be analyzed on the same Western side by side. If the answer is yes, it would be really helpful to try to deplete Sororin in somatic cells by RNA interference to see if the recognized bands do indeed represent Sororin. Likewise, if the Sororin antibodies stained somatic cells in immunofluorescence experiments and these signals were reduced by Sororin specific siRNAs, this would also ad confidence to the interpretation. Alternatively, it could be tested in coimmunoprecipitation experiments from somatic cell lysates if the proteins detected by these antibodies are associated with cohesin. I realize that it is difficult to be absolutely sure about the specificity of antibodies, but since literally all conclusions in this manuscript depend on this specificity the authors need to provide more evidence for this. For an example of how RNAi can be used to control the specificity of Sororin antibodies see Carretero et al., 2013.
3. In Figure 3 , the authors show that Sororin localization at the central region of the SC depends on Sycp1, but not on Rec8 and Smc1β. In mitosis, Sororin binding to DNA depends on Pds5b and Pds5a (Nishiyama et al., 2010; Carretero et. al. 2013). Moreover, in mouse spermatocytes, Pds5b signal is depleted from the chromosome axis when homologues undergo desynapsis at diplotene stage, at the same time Sororin is removed from the central region of the SC. Additionally, Pds5b signal persists in Smc1β-/-spermatocytes (Fukuda and Hoog. 2010). This poses the possibility that Sororin localization in male spermatocytes might still depend on some cohesin complexes (presumably the ones that contain Smc1α and Rad21L) and on Pds5b. For this reason, it would be interesting to analyze Sororin localization in Pds5b-/-spermatocytes. Figures 4 and 5 , the authors show that Sororin localizes to centromeres from late diplotene through anaphase II. They present a very similar pattern of localization to Shugoshin2 (Sgo2) (Gomez et al, 2007) . Sgo2 is required to protect centromeric cohesion and its levels are reduced in cohesin mutants during female mouse meiosis (Lister et al., 2010) . If Sororin and Sgo2 participate in the same pathway to protect centromeric cohesin, one would expect that the centromeric levels of Sororin are also reduced in cohesin mutants. The authors showed that in early stages of prophase I, Sororin localization does not depend on the meiotic cohesin subunits Smc1β and Rec8. However in these later stages of meiosis, if Sororin is indeed protecting centromeric cohesin, one would expect that the centromeric localization of Sororin depends on cohesin. Therefore, it would be important to test whether this centromeric localization is cohesin dependent. The authors could use the cohesin mutants they used in Figure 3 and force spermatocytes in metaphase I using okadaic acid as described in Llano et al., 2014 and assay for Sororin localization. I personally believe the readability of this manuscript for a general audience could be increased by using fewer abbreviations (AE, LE, TF, CE, SC), even though it would increase the length a little bit.
In
Referee #3:
Review of Gomez et al., "Sororin participates in ..."
Cohesin regulators are key to cohesin function, which is essential for proper gametogenesis. Thus, for basic germ cell biology and for considerations of reproductive health it is imperative to understand the role of the pro-and anti-cohesion factors in meiosis. So far no animal models deficient in specific regulators were published that would shed light on these roles and even a thorough description of the spatiotemporal appearance of many regulators is elusive. The mansucript by Gomez et al fills one of these gaps as it describes the status of sororin, a pro-cohesion factor, in spermatocytes.
The scope of the study is obviously limited to describing rather than including manipulation. Still, this study provides important insights into the fate of this central regulator of cohesin not only in wild-type mice but also in cohesin, cohesin protector, and synaptonemal complex mutants. Interestingly, sororin localizes to the central element of the SC where it interacts with SYCP1, indicating either a cohesin-independent role -a hypothesis the authors favor -or that cohesin complexes somehow reach into this region, which is low in nucleic acids and supposed to be low in cohesin.
However, we know little about cohesin's precise arrangement on the AEs and the SC. We alos know nothing about the structure and associations of the cohesin complexes on meiotic chromosomes. It is unclear whether the cohesins form single rings, handcuffed double-rings, multimers or whatever structure and it is by no means certain that cohesins cannot reach into the central element region. As sororin interacts with the N/C head domain interface of cohesin this would imply that the head domains and the associated kleisins/SA proteins are more oriented towards the central elements than assumed. Thus, I suggest that the authors consider this as well, besides postulating a quite nebulous cohesin-independent role. Even in absence of REC8 and SMC1b there is considerable cohesin on prophase I chromosomes, with which sororin may associate.
The role of sororin in supporting (I would rather not say "protecting" since that term is associated with shugoshin) centromeric cohesion appears more in line with previous considerations.
Considering the proposed role of sororin in pairing it would be very informative to add some datasororin/sycp3/sycp1 staining -of Spo11-deficient spermatocytes where non-homologous pairing occurs. This would answer two questions: does sororin loading depend on DSBs and is it specific for homologously paired chromosomes? I am sure that colleagues like Dr Keeney would provide some slides to stain.
The images are generally very nice and conclusive. p. 8: it is very important to take the nature of the antibodies into account when interpreting the IF images, since it may matter a lot which region of SMC3 is recognized by this antibody. Also, the wouldn't it be possible to stain sororin and SMC3 simultaneously using directly labeled antibody? Since the claim of distinct localization of SMC3 and sororin is very important to this paper, one would like to see confirmation by use of another independent antibody, at least for SMC3.
The authors propose co-localization of REC8 and sororin at the SC. This may suggest that the SMC head domains point towards the CR. However, the localization of REC8 in the CR should be more thoroughly demonstrated as it is not entirely clear from Fig. 2 . Figure S1 : it is good to show the specificity of the anti sororin antibodies by Western blot, but then please show the entire gel lane and not only a small area of the gel. Otherwise this figure does not serve its purpose. There may be other bands appearing at other mol mass positions.
There is no sororin at centromeres in Sgo2-/-cells, but is this an effects of absence of Shugoshin or of cohesin removal? The authors may want to co-stain the Sgo2-/-centromeres for SMC3.
The authors suggest association of sororin with SGO2. Do they have data such as IP data to substantiate this proposal?
Minor points: p.7: why is it "surprising" that sororin appears at centromeres? The supportive role for centromeric cohesion is quite along expectations. 
Response to the Editor
Editor´s comments:
Thank you for the submission of your research manuscript to our journal. We have now received the full set of referee reports, which can be found at the end of this e-mail.
As you will see, the referees acknowledge that the findings are potentially interesting. However, all three referees also point out several technical concerns and have a number of suggestions for how the study should be strengthened, and I think that all of them should be addressed. As the reports are below, I will not detail them here. However, addressing the dependence of Sororin on cohesion at later stages of meiosis (referee 2, point 4) and its dependence on double-strand breaks (referee 3), additional co-stainings suggested by referee 1 and referee 3 to substantiate the findings and the avoidance of over-interpretation of data would be necessary. In particular, both referee 2 (point 2) and referee 3 are concerned about the specificity of the Sororin antibodies used in the study, which has to be addressed.
Author response:
The explanation regarding the new experiments done can be found below in the point-by point response to the corresponding referees.
Overall, most concerns seem important, reasonable and should be addressed. An exception is point 3 from referee 2. Given that no data has been published on the meiotic phenotype of Pds5b-deficient mice, it would be out of the scope of the study.
Author Response:
We want to inform that our group, in collaboration with the group led by Dr. Ana Losada (CNIO, Madrid) is currently studying the male meiotic phenotype of conditional knockouts for PDS5A, PDS5B, and double PDS5A/B mice. We agree with you that these new data are out of the scope of the present study.
Given these constructive comments, we would like to invite you to revise your manuscript with the understanding that the referee concerns must be fully addressed and their suggestions taken on board. Please address all referee concerns in a complete point-by-point response. Acceptance of the manuscript will depend on a positive outcome of a second round of review. It is EMBO reports policy to allow a single round of revision only and acceptance or rejection of the manuscript will therefore depend on the completeness of your responses included in the next, final version of the manuscript.
As you will read below in the point-by-point response to the referees, we have now performed all the new experiments that the referees requested. Accordingly, we have changed the extension of previous figures (new panel E in Figure After considering the editor recommendation, we evaluated the possibility of reorganizing our manuscript into the short report format. However, we believe that with that option important information could be excluded while reducing number of figures or text length. We also considered combining figures, but as they are quite rich in content, the combination would reduce too much the size of the cells shown, and therefore, it could lead to a reduced quality or significantly reduced resolution of the visualized structures. For this, we will very much appreciate if we could keep the full article format.
All microscopy figures now include a scale bar, we are sorry for the mistake.
We thank the journal for offering us this opportunity, however, we consider that all the important information is included in the manuscript, and we believe that there is no need to include any additional data separately.
You are able to opt out of this by letting the editorial office know (emboreports@embo.org). If you do opt out, the Review Process File link will point to the following statement: "No Review Process File is available with this article, as the authors have chosen not to make the review process public in this case."
We agree in making public the review process.
Response to the Referee #1
Referee´s comments:
I have only one minor suggestion that would further improve the manuscript.
-It would be helpful to further confirm their conclusion if they could include a data for double staining of Rec8-myc and Sororin at early zygotene in the manuscript.
We are very grateful with referee #1 for his/her kind and positive comments on our work.
Following the referee recommendation, we have changed panel E of previous Figure 2 showing the colabeling of Sororin and REC8-myc in a pachytene spermatocyte by a new panel E showing in this case a zygotene one. Thus, all panels in this Figure show zygotene spermatocytes. The text now reflects this change in page 7 lines 177-178, and in the corresponding figure legend.
Response to the Referee #2
In this study, the authors describe staining patterns obtained with Sororin antibodies in surfacespread mouse spermatocytes and show that this pattern changes in interesting ways during meiotic progression. From zygotene to diplotene Sororin antibodies stain the central region of the synaptonemal complex (SC), where the two homologous chromosomes are synapsed and where the protein SYCP1 is located. Surprisingly, during these stages of prophase I, Sororin staining does not co-localize with cohesin, its binding partner in somatic cells. Cohesin is known to be present at axial/lateral elements, where also Wapl and Pds5B have previously been detected. Moreover, the authors provide evidence that Sororin localization to the central region of the SC does not depend on the meiotic-specific cohesin subunits Rec8 and Smc1b. Based on these results the authors suggest that Sororin might be involved in chromosome pairing and synapsis and that its functions during early stages of prophase I might be independent of cohesin complexes. From late diplotene to anaphase II, Sororin staining is detected at centromeres, where cohesin is known to exist, and its localization there depends on Shugoshin2 (Sgo2). Based on this observation the authors suggest that Sororin might work in combination with Sgo2 in order to protect centromeric cohesion until anaphase II onset. In summary, the authors propose that Sororin might have two distinct and independent roles during male mouse meiosis, a cohesin independent role in chromosome pairing and synapsis, and a cohesin dependent role in protecting centromeric cohesion.
We are very grateful for your suggestions, which are very constructive and helped to improve this manuscript. We are aware that this work might be lacking functional data, but we agree that as this is the first study that shows Sororin in mouse meiosis, our work could be of high interest for the scientific community. We have addressed all recommendations. The experiments done and the changes introduced in the text are detailed below in a point-by-point response.
To avoid overstatements and therefore offer a more fair and accurate title of our work, we have followed this recommendation. Now, the title of our manuscript, taking into account the restrictions in the number of characters, is similar to the title suggested by the referee and reads as follows: "Sororin loads to the synaptonemal complex central region independently of meiotic cohesin complexes".
2. As already mentioned, more work is required to control the specificity of the Sororin antibodies used. For example: Do the two Sororin antibodies mentioned in the Methods give comparable staining patterns? This should be shown.
We agree with the referee that it is important to emphasize that both antibodies used for this study give comparable staining patterns. The new Supplementary Figure 3 , (Fig EV3) shows the similar staining pattern of both antibodies in wild-type zygotene spermatocytes. It is cited in page 6 lines 155-156 as follows: "This pattern of localization of Sororin at the SC central region was consistent with both antibodies used for this study (Fig EV3A and B) ". In addition, and given that one of the most interesting results that our manuscript describes is the presence of Sororin at the SC central region independently of meiotic cohesin complexes, we also show the staining of Sororin with both antibodies on Smc1β -/-pachytene-like spermatocytes (new Supplementary Fig. 3 C,D, Fig EV3C and D) . This additional information is also cited in page 8 lines 230-232 as follows: "This pattern of localization of Sororin at the SC central region in Smc1β -/-spermatocytes was consistently found when employing both antibodies used for this study (Fig EV3C and D) ". The legend of this new figure appears in page 26 line 772.
How does the entire Western blot in Figure S1 look like, are there no other cross-reacting bands? Do these antibodies also cross-react with Sororin in somatic cells? This could be analyzed on the same Western side by side. If the answer is yes, it would be really helpful to try to deplete Sororin in somatic cells by RNA interference to see if the recognized bands do indeed represent Sororin. Likewise, if the Sororin antibodies stained somatic cells in immunofluorescence experiments and these signals were reduced by Sororin specific siRNAs, this would also ad confidence to the interpretation. Alternatively, it could be tested in co-immunoprecipitation experiments from somatic cell lysates if the proteins detected by these antibodies are associated with cohesin. I realize that it is difficult to be absolutely sure about the specificity of antibodies, but since literally all conclusions in this manuscript depend on this specificity the authors need to provide more evidence for this. For an example of how RNAi can be used to control the specificity of Sororin antibodies see Carretero et al., 2013.
As the referee suggests we now show in the new Supplementary Figure 1 (Fig EV1A) the entire Western blots obtained with both anti-Sororin antibodies on testes extracts.
To determine the specificity of the antibodies used in this study, and demonstrate that they are indeed recognizing Sororin, we have performed 2 different experiments:
1. We have knocked-down Sororin in mouse somatic cells as suggested by the referee (please see modified Supplementary Figure 1B and C, Fig EV1B and C) . As recommended by the referee, we took into consideration the specificity experiments of Sororin antibodies described by Carretero et al. (2013) . This publication already describes the specificity of the antibody generated by Dr. Losada (anti-Sor) that we used in this work. However, we have tested it again in comparison with the antibody generated by Dr. Barbero (C-106), which has been validated for the first time in this work. The siRNA experiments were done using mouse C2C12 cells using Sororin siRNA (Thermo Scientific Dharmacon) or control siRNA (Scrambled). Immunoblot analyses of whole cell extracts prepared 48 h after transfection with both antibodies show a significant decrease in the expected band of endogenous Sororin (around 36 kDa). This demonstrates that both antibodies used in this work recognize Sororin in mouse cells.
2. To further support the specificity of the antibodies, we have also overexpressed Sororin in human somatic cells (please see new Supplementary Figure 2, Fig EV2) . HEK 293T cells were transfected with pEGFP-N1-Sororin or empty pEGFP vector as a control. After the verification of the transfection (see new Supplementary Figure 2D, Fig EV2D) , we carried out immunoblot experiments, using both anti-Sor and C-106 antibodies (Fig EV2A and B) , and anti GFP ( Fig  EV2C) . Both anti-Sororin antibodies detect a strong band at around 72 kDa that corresponds with the expected mass of GFP-Sororin (fused protein 36 kDa + 36 kDa). By immunofluorescence, the two antibodies show clear nuclear signals that correlate with the level of overexpression of GFPSororin (Fig EV2E) . We believe that this experiment reinforces the fact that we are using antibodies that specifically detect Sororin.
Both siRNA and overexpression experiments are shown in the modified Supplementary Figure 1  (Fig EV1) and the new Supplementary Figure 2 (Fig EV2) . The methodology is included in the Material and Methods section (page 16 lines 434-443), and the citations to these figures are properly included in the corresponding place of the Results section (page 6 lines 137-139). The legends of these new Supplementary Figures 1 and 2 have also been included in the text.
We believe that the experiments recommended by the referee significantly improve our manuscript and enhance its credibility, and therefore we are grateful for this suggestion.
3. In Figure 3 , the authors show that Sororin localization at the central region of the SC depends on Sycp1, but not on Rec8 and Smc1β. In mitosis, Sororin binding to DNA depends on Pds5b and Pds5a (Nishiyama et al., 2010; Carretero et. al. 2013). Moreover, in mouse spermatocytes, Pds5b signal is depleted from the chromosome axis when homologues undergo desynapsis at diplotene stage, at the same time Sororin is removed from the central region of the SC. Additionally, Pds5b signal persists in Smc1β-/-spermatocytes (Fukuda and Hoog, 2010). This poses the possibility that Sororin localization in male spermatocytes might still depend on some cohesin complexes (presumably the ones that contain Smc1α and Rad21L) and on Pds5b. For this reason, it would be interesting to analyze Sororin localization in Pds5b-/-spermatocytes.
Author response:
The referee is right. For this study we have worked with mice deficient in the meiotic cohesins REC8 and SMC1β. Thus, we can only conclude that Sororin localization at the SC central region is independent on meiotic cohesin complexes with these subunits. Due to the existence of multiple cohesin complexes during mouse meiosis we cannot exclude the presence of other "mitotic" cohesin complexes with RAD21, or other "meiotic" complexes with RAD21L in these mutants with which Sororin could interact. In any case, we have now included a sentence mentioning the possibilities suggested by the referee in the Discussion section (page 12 lines 326-328).
On the other hand, we are currently studying the male meiotic phenotype of mice deficient for PDS5 proteins in collaboration with Dr. Ana Losada (CNIO). We will for sure address the relevance of PDS5 in loading Sororin. However, in our opinion these results are out of the scope of the present manuscript. Figures 4 and 5 , the authors show that Sororin localizes to centromeres from late diplotene through anaphase II. They present a very similar pattern of localization to Shugoshin2 (Sgo2) (Gomez et al, 2007) . Sgo2 is required to protect centromeric cohesion and its levels are reduced in cohesin mutants during female mouse meiosis (Lister et al., 2010). If Sororin and Sgo2 participate in the same pathway to protect centromeric cohesin, one would expect that the centromeric levels of Sororin are also reduced in cohesin mutants. The authors showed that in early stages of prophase I, Sororin localization does not depend on the meiotic cohesin subunits Smc1β and Rec8. However in these later stages of meiosis, if Sororin is indeed protecting centromeric cohesin, one would expect that the centromeric localization of Sororin depends on cohesin. Therefore, it would be important to test whether this centromeric localization is cohesin dependent. The authors could use the cohesin mutants they used in Figure 3 and force spermatocytes in metaphase I using okadaic acid as described in Llano et al., 2014 and assay for Sororin localization.
In

Author response:
This is indeed a good question. Since spermatocytes lacking cohesin subunits SMC1β and REC8 arrest in prophase I, we followed the referee's suggestion to use okadaic acid to force entry into metaphase I.
We proceeded with the okadaic acid experiment using Smc1β -/-spermatocytes (generously provided again by Dr. Rolf Jessberger, Technische Universität Dresden, Germany), in parallel with wild-type spermatocytes as control. In cultured wild-type spermatocytes, Sororin labelling could be detected at the SC central region in prophase I stages, but not at the centromeres of metaphase I chromosomes (new Fig 7A and B) . Thus, we cannot use this protocol to address the importance of cohesin for Sororin recruitment to centromeres. However, we can propose that the phosphatase activity of the SGO2 partner PP2A is likely to be important for Sororin presence at centromeres in metaphase I. We cannot discard that other dynamic processes are also affected. For example, the okadaic acid treated metaphase I chromosomes showed an atypical accumulation of SYCP3 at the interchromatid domain along the arms, and little accumulation of SYCP3 at their centromeres (new Fig 7C and D) . We describe these new results in the main text (page 10 lines 288-307) and discuss them in the Discussion section (page 13 lines 371-375). Figure 7 . If the referees and editor agree, we propose to include this figure in the main text. Although this experiment does not offer additional information about the recruitment of Sororin in the absence of cohesins (in this case SMC1β), it does offer additional and interesting information about the okadaic acid methodology and the possible interactions among PP2A-SGO2-Sororin, which are worth to mention. However, we will be open to changes if the editor or reviewers consider that this figure should be better placed in the Supplementary material.
As mentioned above, this new results are included in the new
Minor points:
Page 3, Ciosk et al. 2000 is not the correct reference for the cohesin loading complex in vertebrates.
Author response:
This reference has been deleted and changed by Gillespie and Hirano (2004) in the text and the Reference section.
I personally believe the readability of this manuscript for a general audience could be increased by using fewer abbreviations (AE, LE, TF, CE, SC), even though it would increase the length a little bit.
As suggested by the referee, we have deleted the abbreviations AE, LE, TF, and CE, and also CR and ACA, to increase the readability of the manuscript. Now the corresponding full names appear in the manuscript. However, we decided to keep the SC (synaptonemal complex) abbreviation.
Response to Referee #3
Cohesin regulators are key to cohesin function, which is essential for proper gametogenesis. Thus, for basic germ cell biology and for considerations of reproductive health it is imperative to understand the role of the pro-and anti-cohesion factors in meiosis. So far no animal models deficient in specific regulators were published that would shed light on these roles and even a thorough description of the spatiotemporal appearance of many regulators is elusive. The manuscript by Gomez et al fills one of these gaps as it describes the status of sororin, a pro-cohesion factor, in spermatocytes.
The scope of the study is obviously limited to describing rather than including manipulation. Still, this study provides important insights into the fate of this central regulator of cohesin not only in wild-type mice but also in cohesin, cohesin protector, and synaptonemal complex mutants. Interestingly, sororin localizes to the central element of the SC where it interacts with SYCP1, indicating either a cohesin-independent role -a hypothesis the authors favor -or that cohesin complexes somehow reach into this region, which is low in nucleic acids and supposed to be low in cohesin. However, we know little about cohesin's precise arrangement on the AEs and the SC. We also know nothing about the structure and associations of the cohesin complexes on meiotic chromosomes. It is unclear whether the cohesins form single rings, handcuffed double-rings, multimers or whatever structure and it is by no means certain that cohesins cannot reach into the central element region. As sororin interacts with the N/C head domain interface of cohesin this would imply that the head domains and the associated kleisins/SA proteins are more oriented towards the central elements than assumed. Thus, I suggest that the authors consider this as well, besides postulating a quite nebulous cohesin-independent role. Even in absence of REC8 and SMC1b there is considerable cohesin on prophase I chromosomes, with which sororin may associate. The role of sororin in supporting (I would rather not say "protecting" since that term is associated with shugoshin) centromeric cohesion appears more in line with previous considerations.
Author response:
We found this suggestion very interesting and we thank the referee for transmitting it to us. We contacted Dr. Scott Keeney (Sloan Kettering Institute, New York) and Dr. Ignasi Roig (UAB, Barcelona), who also possess Spo11 -/-mutant mice. They both were very kind and we received slides with spermatocyte spreads from Spo11 -/-mice (Baudat et al., 2000) . Our results, now included in Figure 3E , showed that Sororin was present at non-homologous paired regions. Consequently, the loading of Sororin to the SC central region is not specific for homologously paired chromosomes. In addition, our results also suggest that Sororin loading into the central region does not depend on the occurrence of double strand breaks.
The origin of the Spo11 -/-mice is included now in the Material and Methods section (page 15 line 390), and new data appear in Figure 3E and have been included in the Results section (page 9 lines 236-245), and accordingly discussed (page 12 lines 338-341).
The images are generally very nice and conclusive.
We are grateful for the kind referee comment, which is highly appreciated. p. 8: it is very important to take the nature of the antibodies into account when interpreting the IF images, since it may matter a lot which region of SMC3 is recognized by this antibody. Also, the wouldn't it be possible to stain sororin and SMC3 simultaneously using directly labeled antibody? Since the claim of distinct localization of SMC3 and sororin is very important to this paper, one would like to see confirmation by use of another independent antibody, at least for SMC3.
We thank the referee suggestion, but we have to take into account that both antibodies (anti-SMC3 and anti-Sororin) were raised in rabbit, so even using directly labeled antibodies we believe that the interpretation of a double immunolocalization would be risky. We bought two commercial anti-SMC3 antibodies from Santa Cruz (a goat polyclonal against rat SMC3, sc-8198; and a mouse monoclonal against rat SMC3, sc-365540) in order to detect simultaneously Sororin and SMC3. Unfortunately, neither of these anti-SMC3 antibodies worked in immunofluorescence. This is the reason by which we preferred to detect Sororin and SMC3 separately.
The K987 rabbit anti-SMC3 antibody that we used was developed by Dr. Barbero against aa. 978-1217 of mouse SMC3. We have also employed a rabbit anti-SMC3 antibody from Abcam (ab-9263) which recognizes the last 100 aa from human SMC3. Both antibodies recognized the axial/lateral elements of the synaptonemal complex, as it has been published using other different antibodies Author response:
We do not suggest that REC8 and Sororin colocalize during prophase I. On the contrary, we suggest that Sororin is located at the central region of the synaptonemal complex, whereas it is known, and we confirm, that REC8 is located along the axial/lateral elements. We are sorry if this was not sufficiently well explained in our manuscript.
As we understand that showing a pachytene with a double immunolocalization of REC8 and Sororin could generate misunderstandings, we have substituted that pachytene with a zygotene spermatocyte where both REC8 and Sororin are detected (as also suggested referee #1). This new panel in Figure  2E confirms that REC8 and Sororin have different localizations. This clarification appears in the text in page 7 lines 175-180. Figure S1 : it is good to show the specificity of the anti sororin antibodies by Western blot, but then please show the entire gel lane and not only a small area of the gel. Otherwise this figure does not serve its purpose. There may be other bands appearing at other mol mass positions.
This was also a concern of referee #2. Please see our response above.
There is no sororin at centromeres in Sgo2-/-cells, but is this an effect of absence of Shugoshin or of cohesin removal? The authors may want to co-stain the Sgo2-/-centromeres for SMC3.
We thank the referee for this question, which is a very important one. The localization of SMC3 at metaphase I centromeres in Sgo2 -/-spermatocytes has been previously reported by our group in collaboration with Dr. Pendás group (see Supplementary Fig S6 in Llano et al, 2008) . In this work, we described that SMC3 localized as a small signal at the inner centromeric domain, as does the cohesin subunit REC8, in metaphase I Sgo2 -/-spermatocytes. However, in the absence of SGO2 cohesins disappear from centromeres in anaphase I. Thus, in these Sgo2 -/-spermatocytes cohesins are present at metaphase I centromeres. We now mention this study in the main text (page 10 lines 284-287).
We unfortunately do not have any IP data that demonstrates the association of SGO2 and Sororin. Our work can only suggest that Sororin is not recruited to the centromeres in the absence of SGO2 (experiments done with the Sgo2 -/-mice, Figure 6 ). We could potentially suggest an interaction, but not a formal association. In our manuscript the affirmation of an "association between Shugoshin and Sororin" does not appear per se. Nevertheless, in order to avoid overstatements and too speculative hypotheses, we have verified that the manuscript does not propose the formal association of Sororin and SGO2.
Minor points:
p.7: why is it "surprising" that sororin appears at centromeres? The supportive role for centromeric cohesion is quite along expectations.
Author response:
We agree with the referee that it was expected to localize Sororin at the centromeres taking into account previous publications. Hence, the word "surprising" has been deleted in the text. p. 8, line 167: as noted above, the high-resolution localization of cohesins at the SC is not yet known.
We agree with the referee that there is much to be described regarding the precise high-resolution localization of cohesins at the SC. Accordingly, we have deleted that cohesins underlie the axial/lateral elements. p. 8: typo "SYC3". Corrected p. 8, line 176: reference for the Rec8-myc transgenics is missing (Nobuaki Kudo et al).
This reference has been included. We thank the referee for noticing this unfortunate mistake. p.14, line 304: typo. The title's section has been changed to Sororin at the centromeres. In addition, the sentence "Thus, Sororin adds to these proteins that load to ther centromeres from CRs" has been changed to this one: "Our results indicate that Sororin is another protein that shows a dynamic relocalization from the SC central regions to the centromeres" (page 13 lines 353-354).
p.15, line 317: not "that", but "as" . Corrected
There are more typos and there is incorrect English -please have it checked.
All the text has been checked and these specific mistakes corrected. English has been revised in the entire document.
2nd Editorial Decision 13 January 2016
Thank you for the submission of your revised manuscript to our editorial offices. We have now received the enclosed reports on it. As you will see, both referees find the manuscript suitable for publication in EMBO reports. Nevertheless, referee 2 has raised some points that should be addressed. Given these evaluations, I would like to give you the opportunity to revise your manuscript, with the understanding that the concerns of referee 2 must be fully addressed.
Supplementary/additional data: The Expanded View format, which will be displayed in the main HTML of the paper in a collapsible format, has replaced the Supplementary information. You can submit up to 5 images as Expanded View. Please follow the nomenclature Figure EV1 , Figure EV2 etc. The figure legend for these should be included in the main manuscript document file in a section called Expanded View Figure Regarding data quantification and statistics, can you please specify the number "n" for how many experiments were performed, the bars and error bars (e.g. SEM, SD) and the test used to calculate pvalues in the respective figure legends? This information must be provided in the figure legends. Please also include scale bars in all microscopy images.
I look forward to seeing a revised version of your manuscript when it is ready. Please let me know if you have questions or comments regarding the revision.
REFEREE REPORTS
In the revised manuscript, the authors have appropriately addressed my minor comment and provided data that further support their conclusion. I fully support publication of the manuscript at EMBO Reports.
The revised version of this study describes the localization of Sororin during mouse spermatogenesis. The authors show a dynamic Sororin localization pattern during prophase I. From zygotene to diplotene, Sororin co-localizes with SYCP1 at the central region of the synaptonemal complex (SC), where the two homologous chromosomes are synapsed. Surprisingly, during these stages of prophase I, Sororin does not co-localize with cohesin, and also not with Wapl and Pds5b, which have been reported to be located at the lateral elements of the SC. Moreover, Sororin localization to the central region of the SC does not depend on the meiotic-specific cohesin subunits Rec8 and Smc1b. Based on these results the authors suggest that Sororin might play a role in chromosome pairing and synapsis independently of meiotic cohesin complexes. From late diplotene to anaphase II, Sororin re-localizes to centromeres and its centromeric localization depends on Sugoshin2 (Sgo2). This suggests that Sororin might work in combination with Sgo2 in order to protect centromeric cohesion until anaphase II onset. Together, these results raise the interesting possibility that Sororin might have two distinct and independent roles during male mouse meiosis, one cohesin-independent and one cohesin dependent function.
In this revised version of the manuscript the authors clarified most of the concerns and criticisms raised in the initial review.
Regarding point 1, the authors changed the title to a more adequate one. The new title, "Sororin loads to the synaptonemal complex central region independently of meiotic cohesin complexes", describes the main finding of the manuscript without overstatements about Sororin function during mammalian meiosis. Concerning point 4, the authors made an effort to test whether the centromeric localization of Sororin depends on cohesin by forcing prophase I arrested Smc1b-/-spermatocytes into metaphase I using okadaic acid. However, Sororin labeling could not be detected at the centromeres of metaphase I chromosomes upon okadaic acid treatment in wild type oocytes. Therefore, the authors could not conclude whether the centromeric localization of Sororin in metaphase I depends on cohesin. Instead, their result suggests that the activity of PP2A, which is recruited to centromeres together with Sgo2, is required for the centromeric localization of Sororin during metaphase I. This is an interesting result complementary to the finding that Sororin localization at centromeres in metaphase I depends on Sgo2. This result should therefore be mentioned and discussed in the main text of this manuscript.
As suggested by reviewer 1, the authors show co-stained images of Sororin and Rec-myc, which indicate more clearly that Sororin and cohesin complexes do not co-localize in early stages of prophase I.
Following a suggestion by reviewer 3, the authors show that in the absence of Spo11 Sororin localizes normally to the central region of the SC. This result indicates that Sororin loading does not depend on double strand breaks formation and that Sororin is present in non-homologous paired regions. This result does, however, not support the hypothesis that Sororin might play a role in homologous pairing, synapsis and recombination. The authors should discuss this more explicitly in the discussion section and take it into account when they speculate on the role of Sororin in early prophase I.
After minor revision to address the suggestions above I would support publication of this manuscript in EMBO Reports. Response to the Referee #1
Response to the Referee #2
Regarding point 1, the authors changed the title to a more adequate one. The new title, "Sororin loads to the synaptonemal complex central region independently of meiotic cohesin complexes", describes the main finding of the manuscript without overstatements about Sororin function during mammalian meiosis.
Concerning point 2, the authors now provided IF images using a second Sororin antibody, and the results obtained confirm the results previously obtained with another antibody. Moreover, the authors have characterized the specificity of the Sororin antibodies Further. The authors now show that Sororin depletion by siRNA in mouse C2C12 cells leads decreases endogenous Sororin level in immunoblot experiments. Unfortunately, the blot presented for the C-106 antibody contains a lot of "background" signal that makes it more difficult to interpret the data. It would help if this could be improved.
In order to improve the western blot in Figure EV1B , we have incubated the same membrane again with the C-106 antibody after a high speed centrifugation to separate possible aggregates. We have also increased the number and length of the washes in TBST. Although there is still background, the image is cleaner and it is now easier to see the clear disappearance of the band corresponding to Sororin after siRNA.
The authors also overexpressed GFP-mouse-Sororin in human HEK 293T cells. Both anti-Sororin antibodies detected a band at around 72 kDa which corresponds to the expected mass of the GFPSororin fusion protein. The authors also showed that the two anti-Sororin antibodies show clear nuclear signals that correlate with the level of overexpression of GFP-Sororin.
Concerning point 3, the authors commented on the possibility that other cohesin complexes, namely Rad21, Rad21L and Smc1a-containing complexes might interact with Sororin and be required for Sororin localization during prophase I.
Concerning point 4, the authors made an effort to test whether the centromeric localization of Sororin depends on cohesin by forcing prophase I arrested Smc1b-/-spermatocytes into metaphase I using okadaic acid. However, Sororin labeling could not be detected at the centromeres of metaphase I chromosomes upon okadaic acid treatment in wild type oocytes. Therefore, the authors could not conclude whether the centromeric localization of Sororin in metaphase I depends on cohesin. Instead, their result suggests that the activity of PP2A, which is recruited to centromeres together with Sgo2, is required for the centromeric localization of Sororin during metaphase I. This is an interesting result complementary to the finding that Sororin localization at centromeres in metaphase I depends on Sgo2. This result should therefore be mentioned and discussed in the main text of this manuscript.
We agree with the referee that this is an interesting finding, and following his/her suggestion, we have now further discussed it in the manuscript. In order to better address this, we have immunodetected SGO2 in cultured spermatocytes treated with okadaic acid, as well as in control cultured spermatocytes. This has allowed us to have a better understanding of our previous results. To present these data and be able to discuss them in the manuscript, we have prepared a small new supplementary Figure EV4 .
We have included the details for the SGO2 antibody in the material and methods section in page 19 line 450. These new data have been included in the results section in pages 10-11 lines 296-309. According to this, the title of this section of the results has been changed to "The centromere loading of Sororin is independent on SGO2" (page 10). These results are now discussed in page 13 lines 375-387 and in page 14 lines 393-398. The summarized last phrase of the discussion has also been slightly modified so that it presents all the conclusions (page 14 lines 404-409). The abstract has also been slightly modified according to these new findings.
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There are no stadistical studies in our work.
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Cell lines used in this study (C2C12 an HEK 293T) are daily used in Dr. Pendás laboratory, co--author in this work. The experiment using cell lines were done in his lab. Tests for mycoplasma contamination are often made. There has never been detected a contamination during the duration on the experiments presented in this work.
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